21 Gene Recurrence Score to Select for Patients with T3N0 ER+HER2-Breast Cancer Likely to Benefit with Postmastectomy Radiation

被引:0
|
作者
Haque, W. [1 ]
机构
[1] Houston Methodist Hosp, Dept Radiat Oncol, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2007
引用
收藏
页码:E4 / E4
页数:1
相关论文
共 50 条
  • [1] 21-gene recurrence score® in patients with primary metastatic ER+HER2-breast cancer
    Barinoff, J.
    Anastasiadou, L.
    Brandi, C.
    Junker-Stein, A.
    Silbermann, J.
    Langenfeld, M.
    Fortmann, C.
    Thill, M.
    CANCER RESEARCH, 2017, 77
  • [2] Oestrogen module of 21-gene recurrence score predicts increased late recurrence for ER+HER2-breast cancer
    Dowsett, M.
    Sestak, I.
    Buus, R.
    Lopez-Knowles, E.
    Cuzick, J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S105 - S106
  • [3] 21-Gene Recurrence Score Predictive for Patients Most Likely to Benefit From Postoperative Radiation Following Breast Conserving Surgery for T1N0 Breast Cancer
    Chevli, N. C.
    Haque, W.
    Tran, K. T.
    Farach, A. M.
    Schwartz, M. R.
    Geyer, C. E.
    Hatch, S. S.
    Butler, E. B.
    Teh, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E205 - E205
  • [4] Survival outcomes according to tumor-infiltrating lymphocytes and 21-gene recurrence score in ER+HER2-breast cancer
    Ahn, S. G.
    Ho, B. Seung
    Minji, L.
    Moon, S.
    Kook, Y.
    Bae, S. J.
    Lee, S. B.
    Jeong, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S338 - S339
  • [5] Impact of the 21-gene recurrence score testing on chemotherapy selection and clinical outcomes in T3N0 luminal breast cancer
    Liu, Ke
    Li, Jia-Yi
    Li, Guan-Qiao
    He, Zhen-Yu
    Wu, San-Gang
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024,
  • [6] Postmastectomy Radiotherapy for T3N0 Breast Cancers: A National Cancer Database Analysis
    Francis, Samual R.
    Frandsen, Jonathan
    Kokeny, Kristine
    Gaffney, David
    Poppe, Matthew
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E18 - E18
  • [7] Predictive factors for recurrence in T2N0 and T3N0 gastric cancer patients
    Hiroaki Saito
    Yuki Murakami
    Kozo Miyatani
    Hirohiko Kuroda
    Tomoyuki Matsunaga
    Yoji Fukumoto
    Tomohiro Osaki
    Masahide Ikeguchi
    Langenbeck's Archives of Surgery, 2016, 401 : 823 - 828
  • [8] Predictive factors for recurrence in T2N0 and T3N0 gastric cancer patients
    Saito, Hiroaki
    Murakami, Yuki
    Miyatani, Kozo
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ikeguchi, Masahide
    LANGENBECKS ARCHIVES OF SURGERY, 2016, 401 (06) : 823 - 828
  • [9] Postmastectomy Radiation Therapy Does Not Improve Outcome for Pathologic T3N0 Breast Cancers
    Li, S.
    Tang, Y.
    Wang, S. L.
    Jin, J.
    Ren, H.
    Song, Y. W.
    Liu, Y. P.
    Fang, H.
    Liu, X. F.
    Yu, Z. H.
    Li, Y. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E30 - E30
  • [10] 21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age? 70 with T1N0 ER/PR+HER2-breast cancer treated with breast conserving surgery and endocrine therapy
    Chevli, Neil
    Haque, Waqar
    Tran, Kevin T.
    Farach, Andrew M.
    Schwartz, Mary R.
    Hatch, Sandra S.
    Butler, E. Brian
    Teh, Bin S.
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : 37 - 43